Malignant Intestinal Neoplasm — Trials

Malignant Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,666
Recruiting: 939
Ph III recruiting: 109
Growth YoY: +12.2%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (772)

clinicaltrialsPublishedShowing 251–300 of 432 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03711240	The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases(CBL)	unknown	Phase 2	40	National Cheng-Kung University HospitalOTHER	1	Mar 13, 2019	clinicaltrials
NCT02624726	Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment(MINOAS)	unknown	Phase 2	31	Hellenic Oncology Research GroupOTHER	1